|
|
Article: HAYES, Inc. Releases Its Health Technology Assessment Report on Drug-Eluting Stents for the Treatment of Coronary Artery Disease.
- Article from:
- PR Newswire
- Article date:
- September 11, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LANSDALE, Pa., Sept. 11 /PRNewswire/ -- HAYES, Inc., the nation's leading provider of evidence-based health technology assessments, announces the release of its report on drug-eluting stents. Drug-eluting stents are used for the minimally invasive treatment of coronary artery obstruction in patients with coronary artery disease who require coronary angioplasty and stenting. A drug-eluting stent is a bare-metal stent that is coated with an antiproliferative drug, which is released gradually into the arterial wall to suppress scar tissue formation within the stent and adjacent areas.
The HAYES report provides an in-depth assessment of the sirolimus-eluting stent, ...